Genetic test could spare breast cancer patients from harsh radiation
NCT ID NCT04069884
Summary
This study is testing whether a genetic test called RecurIndex can help doctors decide which breast cancer patients need radiation to their lymph nodes after surgery. It aims to see if patients with a low-risk genetic score can safely skip this radiation, potentially reducing side effects like swelling and stiffness, without increasing the risk of the cancer coming back. The study will involve about 540 women who have had surgery for breast cancer that spread to a few nearby lymph nodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
RECRUITINGGuangzhou, Guangdong, 510120, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.